Medical Tourism Mazatlán
Phone USA (609) 503-4052
Mesenchymal (human) Stem Cells
Mesenchymal Stem Cells are Regenerative.
✅ YOU ACHIEVE REGENERATE AND REPAIR all your affected Organs, Tissues and Bones.
✅ TRANSFORMS and keeps IN CONTROL all YOUR SYSTEMS (cardiac, immune, nervous, circulatory, etc ...).
✅ PROTECT YOUR HEALTH and stay in GOOD CONDITION to avoid or prevent chronic degenerative diseases, which are what lead to premature death ...
✅ YOU MAKE your ORGANISM become NEW day by day.
MEDICAL CORPORATE OF CELL BIOTECHNOLOGY
Medical Tourism Mazatlan MTM
Working together with the bank of Mesenchymal (human) Stem Cells and the largest Cell Biotechnology Center in the American Continent with more than 18 years of experience in research and development of cell therapy as medical treatment in Mexico.
We have international recognition, such as 4 Doctor Honoris Causa and 1 golden sun for excellence and quality in the performance of our work in the field of Regenerative Medicine; thus having the support of more than 1,500 doctors nationally and internationally.
Our International Scientific Advisory Committee is chaired by Dr. Arnol Caplan of Cleveland, Ohio, regarded as the "father of Stem Cells in the world". We have been pioneers in the fields of regenerative medicine research and innovation, in addition to helping develop new comprehensive therapeutic options to improve the quality of life for our patients.
Our laboratory We have GMP (Good Manufacturing Practice) facilities, ISO 6 classification, which comply with the OFFICIAL MEXICAN STANDARD 059-SSA1-2025 that establishes the good manufacturing practices of the pharmaceutical industry with respect to class A laboratories, in turn the team with those who are in the cell bank, guarantee production practices under the ISO 5 conditions established by current regulations. In this way, we can achieve the highest quality and production control, which is backed by third-party laboratories that have COFEPRIS approval. We are the only laboratory with the 3 permits that currently exist in the management of the development of regenerative medicine based on obtaining, expanding and applying mesenchymal stem cells.
Despite the fact that the sector of the population vulnerable to COVID-19 has already been described, as in any other disease, one of the ways in which a population copes is through collective immunity. If the healthy patients who contract the disease have a greater capacity to stop it, the lower the risk of transmission. This is because the body will be able to counteract the infection in a more effective and faster way. On the other hand, they can free the health system to focus on the people who really need it.
Treatment with mesenchymal stem cells (MSC) is known to have an immunomodulatory effect and possess the ability to modify the cellular environment, helping to prepare the body for the stress that is continuously received from the environment, as well as to cope with some infection.
Therefore, this treatment is recommended as a form of prevention, both for vulnerable patients and for the general population.
However, it is necessary to clarify that not every cell works. In patients treated in China, mesenchymal stem cells (MSC) were cultivated under the criteria of good manufacturing practice (GMP) and with rigorous quality control. It is important that the regenerative treatment comes from a Stem Cell Bank that can verify cell purity, identity and viability to ensure the success of the treatment.
In China, the use of up to 150 million mesenchymal stem cells (CTM) distributed in three doses in some severe cases of COVID-19 was approved. The application of mesenchymal stem cells (CTM) resulted in the improvement of all transplant patients.
These results indicate that the treatment with Human Stem Cells may be one of the most effective to combat the complications of COVID-19.
Human Stem Cells are cells with an immunomodulatory capacity already recognized in different scientific reports around the world. Its effectiveness has been shown above all in inflammatory diseases or the immune system. Such is the well-known case of its use against graft-versus-host disease (GvHD), in which mesenchymal stem cells (MSC) are administered to prevent and decrease the inflammatory action produced by organ transplantation.
Through their already known functions, they decrease the cascade of pro-inflammatory molecules and stimulate the immune system itself to produce anti-inflammatory cells and molecules, this reduces harmful inflammation. In addition, they help the body to recover naturally, since they secrete growth and angiogenic factors that allow the regeneration of damaged tissue.
Stem Cell Treatment